Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis
Clinical trial NCT05218096 · TERMINATED
Trial details
- NCT number
- NCT05218096
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-27
- Primary completion
- 2023-11-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.